Balstilimab (Anti-PDCD1 / PD-1 / CD279)

Balstilimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting the programmed cell death 1 (PD-1, PCD-1; PDCD1). It exhibits potential treatment of cervical cancer. MW :137.3 KD.
Supplier Selleck Chemicals
Product # A3027
Sku # A3027-1mg*5
Pricing 1mg*5, $1690.00
Feedback